Literature DB >> 2865212

Activation of the alternative and classical complement pathways by Entamoeba histolytica.

J Calderon, R D Schreiber.   

Abstract

Entamoeba histolytica HM1 supported the activation of human alternative and classical complement pathways in the absence of ameba-reactive antibodies. Nonimmune serum depleted of C1q and factor D (NHS s C1q + D) and reconstituted with C1q was able to specifically deposit C3b onto trophozoites and produce lysis. This activity was not modified by the absorption of serum on E. histolytica. Serum depleted of factor B allowed C3b binding to amebae. Serum devoid of C4 effected only small amounts of C3 uptake. The kinetics of lysis of E. histolytica by serum in the presence of Mg-EGTA [ethylene glycol-bis(beta-aminoethyl ether)-N,N,N',N'-tetraacetic acid] (lacking classical pathway function) or by NHS s C1q + D and reconstituted with factor D was slow and only produced one-half the amount of lysis produced by NHS s C1q + D supplemented with C1q. These results indicate that the surface of the ameba can promote complement activation by the classical pathway, without the participation of specific antibodies, and that the magnitude of this activation is greater than that induced by the alternative pathway.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 2865212      PMCID: PMC261992          DOI: 10.1128/iai.50.2.560-565.1985

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  19 in total

1.  Interactions between Entamoeba histolytica and complement.

Authors:  G Huldt; P Davies; A C Allison; H U Schorlemmer
Journal:  Nature       Date:  1979-01-18       Impact factor: 49.962

2.  Surface-specific iodination of membrane proteins of viruses and eucaryotic cells using 1,3,4,6-tetrachloro-3alpha,6alpha-diphenylglycoluril.

Authors:  M A Markwell; C F Fox
Journal:  Biochemistry       Date:  1978-10-31       Impact factor: 3.162

3.  A new medium for the axenic cultivation of Entamoeba histolytica and other Entamoeba.

Authors:  L S Diamond; D R Harlow; C C Cunnick
Journal:  Trans R Soc Trop Med Hyg       Date:  1978       Impact factor: 2.184

4.  Activation of the alternative pathway of complement by Entamoeba histolytica.

Authors:  L Ortiz-Ortiz; R Capin; N R Capin; B Sepúlveda; G Zamacona
Journal:  Clin Exp Immunol       Date:  1978-10       Impact factor: 4.330

5.  Peroxidase labelled antibody and Fab conjugates with enhanced intracellular penetration.

Authors:  S Avrameas; T Ternynck
Journal:  Immunochemistry       Date:  1971-12

6.  Raji cell injury and subsequent lysis by the purified cytolytic alternative pathway of human complement.

Authors:  R D Schreiber; M K Pangburn; R G Medicus; H J Müller-Eberhard
Journal:  Clin Immunol Immunopathol       Date:  1980-03

7.  Activation and regulation of the first complement component.

Authors:  N R Cooper
Journal:  Fed Proc       Date:  1983-01

8.  A one-step procedure for preparation of classical pathway (C1q) and alternative pathway (factor D) depleted human serum.

Authors:  F Praz; M C Roque Antunes Barreira; P Lesavre
Journal:  J Immunol Methods       Date:  1982       Impact factor: 2.303

9.  Activation of complement by variant-specific surface antigen of trypanosoma brucei.

Authors:  A J Musoke; A F Barbet
Journal:  Nature       Date:  1977-12-01       Impact factor: 49.962

10.  Mechanism of action of factor D of the alternative complement pathway.

Authors:  P H Lesavre; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1978-12-01       Impact factor: 14.307

View more
  12 in total

1.  Intestinal invasion by Entamoeba histolytica.

Authors:  Shahram Solaymani-Mohammadi; William A Petri
Journal:  Subcell Biochem       Date:  2008

2.  Loss of susceptibility to complement lysis in Entamoeba histolytica HM1 by treatment with human serum.

Authors:  J Calderon; R Tovar
Journal:  Immunology       Date:  1986-07       Impact factor: 7.397

3.  Anti-GK1 antibodies damage Taenia crassiceps cysticerci through complement activation.

Authors:  Guadalupe Núñez; Nelly Villalobos; Cinthia P Herrera; José Navarrete-Perea; Adriana Méndez; José J Martinez-Maya; Raúl J Bobes; Gladis Fragoso; Edda Sciutto; Laura Aguilar; Irene P Del Arenal
Journal:  Parasitol Res       Date:  2018-06-06       Impact factor: 2.289

4.  Lysis of complement-sensitive Entamoeba histolytica by activated terminal complement components. Initiation of complement activation by an extracellular neutral cysteine proteinase.

Authors:  S L Reed; I Gigli
Journal:  J Clin Invest       Date:  1990-12       Impact factor: 14.808

5.  Resistance of highly pathogenic Naegleria fowleri amoebae to complement-mediated lysis.

Authors:  L Y Whiteman; F Marciano-Cabral
Journal:  Infect Immun       Date:  1989-12       Impact factor: 3.441

Review 6.  Cysteine proteinases and the pathogenesis of amebiasis.

Authors:  X Que; S L Reed
Journal:  Clin Microbiol Rev       Date:  2000-04       Impact factor: 26.132

7.  Susceptibility of pathogenic and nonpathogenic Naegleria spp. to complement-mediated lysis.

Authors:  L Y Whiteman; F Marciano-Cabral
Journal:  Infect Immun       Date:  1987-10       Impact factor: 3.441

8.  Role of immunoglobulin G in killing of Borrelia burgdorferi by the classical complement pathway.

Authors:  S K Kochi; R C Johnson
Journal:  Infect Immun       Date:  1988-02       Impact factor: 3.441

9.  Complement resistance of pathogenic Entamoeba histolytica mediated by trypsin-sensitive surface component(s).

Authors:  C Hamelmann; B Urban; B Foerster; R D Horstmann
Journal:  Infect Immun       Date:  1993-05       Impact factor: 3.441

10.  Trophozoites of Entamoeba histolytica express a CD59-like molecule in human colon.

Authors:  J Ventura-Juárez; R Campos-Rodríguez; R A Jarillo-Luna; L Muñoz-Fernández; J A Escario-G-Trevijano; J Pérez-Serrano; J L Quintanar; E Salinas; F R Villalobos-Gómez
Journal:  Parasitol Res       Date:  2008-11-19       Impact factor: 2.289

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.